OPEN END TURBO SHORT - BECTON DICKINSON AND CO. Share Price

Certificat

DE000ME8PC78

Real-time Bid/Ask 13:09:58 22/05/2024 BST
3.71 EUR / 3.88 EUR +2.02% Intraday chart for OPEN END TURBO SHORT - BECTON DICKINSON AND CO.
Current month-2.11%
1 month-4.12%
Date Price Change
22/05/24 3.68 -1.08%
21/05/24 3.72 +5.68%
20/05/24 3.52 -2.22%
17/05/24 3.6 +2.27%
16/05/24 3.52 +0.86%

Delayed Quote Börse Stuttgart

Last update May 22, 2024 at 12:06 pm

More quotes

Static data

Product typeKnock-Out ohne Stop Loss
Buy / SellPUT
Underlying BECTON, DICKINSON AND COMPANY
Issuer Morgan Stanley
WKN ME8PC7
ISINDE000ME8PC78
Date issued 13/02/2024
Strike 274.7 $
Maturity Unlimited
Parity 10 : 1
Emission price 2.98
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 4.15
Lowest since issue 2.52
Spread 0.17
Spread %4.39%

Company Profile

Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.; - clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Sector
-
More about the company

Ratings for Becton, Dickinson and Company

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Becton, Dickinson and Company

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
234.9 USD
Average target price
279 USD
Spread / Average Target
+18.79%
Consensus